Page last updated: 2024-10-24

verapamil and Uterine Cervical Neoplasms

verapamil has been researched along with Uterine Cervical Neoplasms in 5 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX.

Research Excerpts

ExcerptRelevanceReference
"Verapamil was employed as a comparative agent."1.37Stemona alkaloids, from traditional Thai medicine, increase chemosensitivity via P-glycoprotein-mediated multidrug resistance. ( Ampasavate, C; Chanmahasathien, W; Greger, H; Limtrakul, P, 2011)
"Tamoxifen did not inhibit cell-free C6-GC synthesis in the P-gp/off or P-gp/on homogenates."1.36Expression of P-glycoprotein in HeLa cells confers resistance to ceramide cytotoxicity. ( Cabot, MC; Chapman, JV; Gouazé-Andersson, V, 2010)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chanmahasathien, W1
Ampasavate, C1
Greger, H1
Limtrakul, P1
Chapman, JV1
Gouazé-Andersson, V1
Cabot, MC1
Smellie, M1
Kelland, LR1
Thurston, DE1
Souhami, RL1
Hartley, JA1
Osmak, M1
Chou, CY1
Shen, MR1
Wu, SN1

Other Studies

5 other studies available for verapamil and Uterine Cervical Neoplasms

ArticleYear
Stemona alkaloids, from traditional Thai medicine, increase chemosensitivity via P-glycoprotein-mediated multidrug resistance.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2011, Jan-15, Volume: 18, Issue:2-3

    Topics: Alkaloids; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line

2011
Expression of P-glycoprotein in HeLa cells confers resistance to ceramide cytotoxicity.
    International journal of oncology, 2010, Volume: 37, Issue:6

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Cell Surv

2010
Cellular pharmacology of novel C8-linked anthramycin-based sequence-selective DNA minor groove cross-linking agents.
    British journal of cancer, 1994, Volume: 70, Issue:1

    Topics: Anthramycin; Antibiotics, Antineoplastic; Benzodiazepines; Cross-Linking Reagents; DNA Damage; DNA,

1994
Multifactorial molecular mechanisms are involved in resistance of preirradiated human cervix carcinoma cells to cis-dichlorodiammineplatinum (II) and vincristine.
    Neoplasma, 1993, Volume: 40, Issue:2

    Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine

1993
Volume-sensitive chloride channels associated with human cervical carcinogenesis.
    Cancer research, 1995, Dec-15, Volume: 55, Issue:24

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; ATP Binding Cassette Transporter, Subfamily B, Mem

1995